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Abstract.   The protein-ligand binding interactions studies were carried out by performing dockings of  the ligands  that were 
found to be competitively inhibiting the activities of  the DEN2 NS2B/NS3 serine protease onto the catalytic triad of  a model 
of  DEN2 NS2B/NS3 protease.   Results indicate the importance of  three out of  the five residues reported to be essential for 
binding activities of  the NS2B/NS3 serine protease. These residues are Tyr-150, Asn-152 and Gly-153.  In addition, Ser-135 
and Gly-151 were also found to be very important in forming hydrogen bonds with the inhibitors. Moreover, Ser-131, Pro-132, 
Tyr-150 and Asn-152 were found to be important for van der Waals interaction of  the ligand, while Val-52, Leu-128, Pro-132 
and Val-155 are involved in hydrophobic interaction with the inhibitors. 
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INTRODUCTION
Dengue is a serious disease that is endemic in over 100 
countries, with more than 2.5 billion people at risk for 
epidemic transmission.  About 100 million cases of  Dengue 
Fever (DF) and 500 000 cases of  Dengue Haemorrhagic 
Fever (DHF) have been reported globally and this figure 
has been on the rise in the recent years.  It was reported that 
40 % of  the world’s populations to be at risk from dengue 
with no effective treatment, vaccine or drug (Kautner, et al, 
1997, Monath, 1994).  The Ministry of  Health Malaysia, 
reported that in Malaysia dengue fever killed 44 people in the 
first four months of  2007 and a record number of  dengue 
suspected cases were seen in 2007 with 900 suspected cases 
in the first week of  June.  This is an increase of  more than 
100 percent compared to the same period of  2006 (Sun 
Malaysia, 2007).
     The main dengue vector is the female Aedes aegypti and 
Aedes albopictus.  A mosquito feeding on a person during the 
first to fifth days of  illness can transmit the virus to another 
person. Following the virus incubation period for 8-10 days 
in the vector, the virus can be transmitted by an infected 
mosquito to susceptible individuals through blood feeding 
(WHO, 2002).  
     DF and DHF are caused by the dengue virus which 
is a member of  the Flaviviridae. There are four serotypes 
of  dengue virus, DEN1, DEN2, DEN3 and DEN4, with 
DEN2 being the most prevalent.  The RNA genome of  
DEN2 contains 10 723 nucleotides and encodes a large 
polyprotein precursor of  3 391 amino acid residues which 
consist of  three structural proteins (C, prM and E) and seven 
non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B, NS5) (Irie et al., 1989).  Optimal activity of  the NS3 
serine protease is required for the maturation of  the virus 
and the presence of  the NS2B co-factor is a pre-requisite 
for the optimal catalytic activity of  NS3 (Bianchi and Pessi, 
2002 and references therein).  Studies revealed that NS3, 
the second larger protein encoded by the virus, contains a 
serine proteinase catalytic triad within terminal region of  
180 amino acid residues and that it requires the 40 amino 
acid residues of  NS2B for protease activity (Chambers et 
al., 1993; Arias et al. 1993; Jan et al., 1995).  The processing 
of  the polyprotein precursor occurs co-translationally as 
well as post-translationally and is performed by either the 
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host signalase in association with the membranes of  the 
endoplasmic reticulum or the viral protease.  The NS2B/NS3 
component of  the protease activates the cleavage in the non-
structural region of  the viral polyprotein at NS2A/NS2B, 
NS2B/NS3, NS3/NS4A and NS4B/NS5 junctions (Arias 
et al., 1993; Teo et al., 1997; Yusof  et al., 2000).  These sites 
have, in common, a pair of  dibasic amino acids, Lys-Arg, 
Arg-Arg, Arg-Lys and occasionally, Gln-Arg at the P1 and P2 
positions, followed by the short chain amino acid, Gly, Ser or 
Ala at the P1’ position (see Schechter and Berger, 1967 for 
the nomenclature).  In addition, the viral protease has been 
found to cleave internally within NS2A (Nestorowicz et al., 
1994) and NS3 (Falgout et al., 1991).  
     Mutational analyses revealed the importance of  several 
amino acid residues that are highly conserved among the 
flaviviruses, where 5 putative substrate binding residues 
(Asp-129, Phe-130, Tyr-150, Asn-152 and Gly-153) were 
proposed (Valle and Falgout, 1998). Computer modelling and 
analysis of  the substrate binding at the catalytic triad of  the 
crystal structure of  NS3 without its NS2B cofactor revealed 
that Gly-133 and Ser-135 to be the most likely to form the 
oxyanion hole (Murthy et al., 1999).  Hydrogen bonding 
interactions have been observed between the main chain of  
P1 and P2 residues with appropriate main chain atoms of  
Gly-153 and Asn-152 to generate the short section of  β-sheet 
common in serine protease-inhibitor interactions (Read and 
James, 1986). Three residues, Ser-131, Tyr-150, and Ser-163, 
are within the S1 pocket. A serine side chain at P1’ fits into 
the S1’ pocket formed by the catalytic His-51 and Ser-135 
and residues Gly-35, Ile-36, and Val-52. The Oε1 atom  of  
Asn-152 forms a salt bridge/hydrogen bond with Nε of  the 
P2 Arg in the modelled complex (Murthy et al., 1999).
     In this paper we describe the in silico study of  the molecular 
binding interactions between the DEN2 NS2B/NS3 serine 
protease with competitive inhibitors that are observed in vitro 
(Tan et al, 2005).  Although the crystal structure of  DEN2 
NS3 has been reported (Murthy et al., 1999), the absence of  
NS2B cofactor therein makes the mechanism of  proteolytic 
process activation unclear. The orientation of  the carboxyl 
side chain of  Asp-75 away from His-51 in the catalytic triad 
of  NS3 crystals formed an open conformation that may lead 
to the inefficiency of  proteolytic activity. Previous study on 
the homology model generated from the HCV template 
have shown a better quality of  protein folding and side chain 
conformation (Lee et al., 2006), as well as the orientation 
of  the catalytic triad to enable efficient proton transfer, as 
compared to crystal structure of  NS3 in absence of  N2SB as 
cofactor. Hence, in this study, the crystal structure of  the NS3 
with its cofactor NS4A complex in HCV was chosen as the 
template to generate the DEN2 NS2B/NS3 model.  Binding 
interactions between three competitive inhibitors (based 
on experimental studies) and dengue virus serine protease 
were studied by performing protein-ligand docking using 
AUTODOCK 3.05.  It is hoped that the results obtained 
would provide some insights into the molecular interaction 
of  these ligands and the NS2B/NS3 protease and into their 
mechanism of  action. 
MATERIAL AND METHODS
Homology model building.   The Modeller software package 
(mod6v2) was used to build the NS2B/NS3 protease complex 
model (Sali and Blundell, 1993).  The homology modelling 
of  NS2B/NS3 of  dengue virus type 2 was performed with 
HCV serine protease NS3/4A (pdb ID. 1jxp) as a template. 
The sequence alignment was carried out based on published 
results (Brinkworth et al., 1999). The model generated was 
then submitted to the UCLA bioinformatics server for 
evaluation of  its quality using PROCHECK (Morris et al., 
1992), VERIFY3D (Bowie et al., 1991) and ERRAT (Colovos 
and Yeates, 1993).
Docking experiment using homology model .   The docking of  
three competitive bioactive molecules, 4-hydroxypanduratin 
A (1), panduratin A (2) and ethyl 3-(4-(hydroxymethyl)-2-
methoxy-5-nitrophenoxy)propanoate (3) (termed as “ester 
(3)”  in later discussion), onto the catalytic triad of  the serine 
protease were performed using AUTODOCK 3.05 software 
package (Morris et al., 1998). The homology model of  DEN2 
NS2B/NS3 protease molecule was added polar hydrogen 
atoms and its non-polar hydrogen atoms were merged. 
Kollman charges were assigned and solvation parameters 
were added to this enzyme molecule. For the ligands, non-
polar hydrogen atoms were merged with Gasteiger charges 
assigned. All rotatable bonds of  ligands were set to be 
rotatable. Docking was performed using genetic algorithm 
and local search methods. A population size of  150 and 10 
millions energy evaluations were used for 100 times searches, 
with a 60 x 60 x 60 dimension of  grid box size and 0.375 Å 
grid spacing around the catalytic triad. Clustering histogram 
analyses were performed after the docking searches.  The 
best conformations were chosen from the lowest docked 
energy that populated in the highest number of  molecules 
in a particular cluster with not more than 1.5 Å root-mean-
square deviation (rmsd). The H-bond, van der Waals and 
other binding interactions were analysed using Viewerlite 
4.2 (Accelrys Software Inc.). 
RESULTS AND DISCUSSION
Homology model of DEN2 NS2B/NS3.   Although the 
overall sequence identity between DEN2 NS2B/NS3 and 
HCV NS3/NS4A was only 14.8%, the region surrounding 
the catalytic triad of  the protease and the residues involved 
in the substrate binding showed a high level of  sequence 
identity and is conserved, as reported by Brinkworth and 
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co-workers (Brinkworth et al., 1999). In addition, the results 
obtained from PROCHECK (all the non-glycine residue are 
in allowed region), VERIFY3D (90.4) and ERRAT (77.1) 
revealed the good quality of  the model built as described by 
Lee and co-workers (Lee et al., 2006).
Inhibition of bioactive compounds towards DEN2 NS2B/
NS3 .   Several competitive inhibitors towards DEN2 serine 
protease activity have been discovered through a substrate-
based approach by mimicking the polyprotein cleavage 
junctions (Chanprapaph et al., 2005).  In addition, α-keto 
peptidomimetic (Leung et al., 2001) compounds and guanidine 
derivatives (Ganesh et al., 2005) have also been targeted as 
competitive inhibitors towards the DEN2 serine protease.  In 
our lab, the natural products, 4-hydroxpanduratin A (1) and 
panduratin A (2) as well as the synthesized compound, ethyl 3-
(4-(hydroxymethyl)-2-methoxy-5-nitrophenoxy)propanoate, 
(3) were found to competitively inhibit the activity of  the 
DEN2 serine protease.  The structures of  these compounds 
are shown in Figure 1.   The Ki values for these compounds 
obtained from inhibition study using recombinant NS2B/
NS3 enzyme showed that 4-hydroxypanduratin A (1) to be 
the most potent, followed by panduratin A (2) and ester (3) 
(Table 1).
Active site docking.   The three inhibitors (Figure 1) were used 
as ligands in the binding interaction studies with the active site 
of  the DEN2 serine protease.  Docking of  these compounds 
to the active sites revealed 4-hydroxypanduratin A (1) to have 
the lowest docked energy, followed by panduratin A (2) and 
the ester (3) (Table 2).  
     These results are parallel to the Ki value observed 
experimentally for these compounds. Although panduratin 
A (2) showed the best free energy of  binding, estimated 
inhibition constant and intermolecular energy, it has a 
higher torsional free energy and internal energy values than 
4-hydroxypanduratin A (Table 2).  This may be the cause 
of  its weaker binding to the enzyme when compared to 
4-hydroxypanduratin A (1).  The ester (3) with the most 
number of  rotatable torsion points suffer a higher torsional 
free energy resulting in a lower binding affinity as compared 
to the other ligands.
     All the ligands showed reasonably low internal energy 
indicating that the docked conformers were in their most 
favourable conformations.  The spatial arrangement of  the 
three ligands bound to the active site of  DEN2 NS2B/NS3 
serine protease is shown in Figure 2.
Interactions between inhibitors and residues in NS2B/NS3. 
Hydrogen bond analysis was performed on the docked 
NS2B/NS3 protein complex to determine the possibility 
of  hydrogen bonding or salt bridge formation between the 
ligands and the active site of  NS2B/NS3 protease. The 
criteria for hydrogen bond interaction used is when the 
distance between the hydrogen and the heteroatom is within 
Figure 1. Structure of  4-hydroxypanduratin A (1), pandu-
ratin A (2) and ethyl 3-(4-(hydroxymethyl)-2-methoxy-5-
nitrophenoxy)propanoate (3).
 Compound Ki, mM
 
4-OH-panduratin A (1) 21
 Panduratin A (2) 25
 Ester (3) 59
Table 1. Ki values of  the found competitive inhibitors Figure 2.   Connolly surface representations of  the active site of  
serine protease domain of  the NS2B/3 protease of  DEN2 with 
the bound ligands, (a) 4-hydroxypanduratin A (1), (b) ester (3) and 
(c) panduratin A (2), which is shown in stick model. Connolly sur-
face of  the active site of  the protease is coloured according to 
a charge spectrum: acidic groups are red, basic groups are blue 
and neutral groups are white. Residues labeled in black are those 
that may involve in H-bond/salt bridge interaction with ligand. 
Residues in labeled blue are involved in van der Waals interactions, 
while those in green are involved in both the van der Waals and 
H-bond interactions.
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the range of  2.5-3.5 Å and the bond angle is at 109º-110º.
Overall, these ligands exhibited binding interactions within 
the active site and the residues as suggested by Bazan and 
Fletterick (Bazan and Fletterick, 1989).  
     Oxyanion holes have been observed to interact with 
ligands within the active site of  the serine protease at the 
residues Gly-133 and Ser-135 by Murthy et al. (Murthy et 
al.,1999).  Interestingly, in our study, all the ligands were 
observed to form hydrogen bond with the carbonyl group 
of  Gly-151 and the hydroxyl of  Ser-135 side chain (Table 
3).  This seemed to suggest a different binding mode of  the 
ligands to the enzyme than those observed by Murthy and 
his co-workers.  The amino group of  the residues backbone 
Gly-133 and Ser-135 were suggested by Murthy et al. to be 
involved in forming the oxyanion hole.   However, in our 
study, the oxyanion holes formation by these residues was 
observed only in the binding interaction with the ester (3) 
but not with the 4-hydroxypanduratin (1) and panduratin A 
(2) (Table 3).
     Substitution of  the hydroxyl group in the 4-
hydroxypanduratin A (1) with the methoxy group seemed to 
lead to a higher Ki value observed with panduratin A (2).  This 
could be attributed to the loss of  hydrogen bonding with the 
carboxyl of  Asp-75 side chain in panduratin A (2) which was 
observed with 4-hydroxypanduratin A (1).  Similarly, with the 
ester (3), a higher Ki value observed could be attributed to its 
structural flexibility.  However, this flexibility was somewhat 
  Ligand 4-Hydroxypanduratin A (1) Panduratin A (2) Ester (3)
 1. Estimated Free Energy of  Binding -7.4 -7.7 -6.1
 2. Estimated Inhibition Constant, mM (Ki) +3.9 +2.3 +33.6
 3. Final Docked Energy -10.2 -10.1 -9.2
 4. Final Intermolecular Energy -8.9 -9.6 -8.9
 5. Final Internal Energy of  Ligand -1.3 -0.6 -0.3
 6. Torsional Free Energy +1.6 +1.9 +2.8
Table 2. Energies (in kcal/mol) calculated using AUTODOCK 3.05
*  Estimated Free Energy of  Binging is derived from the Final Internal Energy (4) and Torsional Free Energy (6) while the Final Docked Energy is the combination of  Final Internal Energy (4) and 
Final Internal Energy of  Ligand (5).
 Residues 4-Hydroxypanduratin A (1) Ester (3) Panduratin A (2)
 His-51  √ 
 Asp-75 √  
 Ser-131  √ 
 Gly-133  √ 
 Thr-134  √ 
 Ser-135 √ √ √
 Gly-151 √ √ √
 Asn-152  √ 
 Val-155  √ 
Table 3.   Residues in the active site of  DEN2 NS2B/NS3 that are 
involved in hydrogen bonding with the various ligands
 Residues 4-Hydroxypanduratin A (1) Panduratin A (2) Ester (3)
 His-51 √ √ 
 Ser-131 √ √ √
 Pro-132 √ √ √
 Gly-133 √ √ 
 Ser-135  √ √
 Tyr-150 √ √ √
 Asn-152 √ √ √
 Gly-153  √ √
Table 4.   Residues in the active site of  DEN2 NS2B/NS3 that are 
involved in van der Waals interaction
compensated by additional hydrogen bonds between the ester 
and Ser-131, Thr-134, Asn-152 and Val-155. 
     All the ligands exhibited van der Waals interactions with 
Ser-131, Pro-132 and Try-150, suggesting the importance of  
these three residues as part of  the van der Waals specificity 
pocket.  Nevertheless, His-51, Gly-133, Ser-135, Asn-152 
and Gly-153 may also play important roles in such binding 
interactions (Table 4). The small hydrophobic specificity 
pocket for P1 which is formed by the residues Leu-135, Phe-
154 and Ala-157 in HCV NS3/4A protease (Love et al., 1996) 
is equivalent to the residues Ser-131, Tyr-150 and Gly-153 
in the DEN2 NS2B/NS3 protease (Brinkworth et al., 1999). 
These latter residues were found to be involved in the van der 
Waals interactions with the ligands (1), (2) and (3) suggesting 
a more hydrophilic interaction of  the enzyme to the ligand 
as compared to the more hydrophobic interaction observed 
in HCV NS3/4A protease. In addition, Ser-131 which has 
been shown to not be important as a binding residue in 
previous study (Brinkworth et al., 1999) is now observed to 
be involved in the van der Waals interaction with the ligands 
in our docking study.
     Additional interactions were observed between the ligands 
(1) and (2) with the residues Val-52, Leu-128, Pro-132 and Val-
155 in the hydrophobic site in the binding pocket of  DEN2 
serine protease whereby the orientation of  these hydrophobic 
residues seemed to fit in with the ligands (1) and (2).  Here, the 
phenyl group of  the hexacyclic portion in ligands (1) and (2) 
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fitted into the hydrophobic pocket consisting of  the residue 
Val-52, whilst the 2-methyl-2-butylene, another hydrophobic 
side-chain in the ligands, fitted into a second hydrophobic 
pocket formed by the residues Leu-128, Pro-132 and Val-155 
(Figure 3, a and b). The ester group in (3) also fitted into the 
Leu-128, Pro-132 and Val-155 hydrophobic pocket but not 
with the residue Val-52 (Figure 3, c). 
     Another form of  interaction observed with 
4-hydroxypanduratin A (1) and panduratin A (2) but not 
observed in previous studies is the π-π type aromatic 
interaction (Figure 4).  In this case, the position of  the 
trisubstituted phenyl moiety in both the ligands (1) and (2) is 
located at about 3 - 4.2 Å and parallel to the pentacyclodiazo 
side-chain of  His-51 which enabled a π-π type aromatic 
interaction to occur.  However, such interaction was not 
been observed with the ester (3).  The lack of  both the 
hydrophobic group that could interact with Val-52 and 
aromatic interaction presumably has made the ester (3) less 
active as observed from its Ki value when compared to the 
two ligands.
CONCLUSIONS
The docking of  various ligands with competitive activities 
to the model of  DEN2 NS3 serine protease complexed 
with NS2B co-factor was carried out.  Several modes of  
interactions such as H-bonding, van der Waals as well as π-
Figure 3.   Hydrophobic interaction illustration between ligands 
(in stick) and NS2B/NS3 protease (in ribbon). Ligand in a: 4-hy-
droxypanduratin A; b: panduratin A; and  c: ester(3). Residues that 
involved in hydrophobic interaction are shown as connolly sur-
face. Non-polar hydrogen of  ligands has been omitted for clarity.
Figure 4. Molecular orientation of  (a): 4-hydroxypanduratin A; 
and (b): panduratin A at the catalytic triad of  NS2B/NS3. Docked 
ligand are shown in stick model, whereas catalytic triad residues are 
shown in ball and stick model. The double-ended arrow showed 
the suggested π-π type aromatic interaction between pentacyclodi-
azo side-chain of  His-51 and the phenolic moiety of  the ligands.
π interaction were observed between these ligands and the 
DEN2 NS2B/NS3 active sites.  These findings have provide 
further understanding on the binding interaction of  the 
catalytic triad of  the DEN2 NS2B/NS3 serine protease, thus 
giving input into the mode of  action of  the catalytic triad.
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